ATE71141T1 - Diagnosesystem zum nachweis von cytomegalovirus. - Google Patents

Diagnosesystem zum nachweis von cytomegalovirus.

Info

Publication number
ATE71141T1
ATE71141T1 AT85902741T AT85902741T ATE71141T1 AT E71141 T1 ATE71141 T1 AT E71141T1 AT 85902741 T AT85902741 T AT 85902741T AT 85902741 T AT85902741 T AT 85902741T AT E71141 T1 ATE71141 T1 AT E71141T1
Authority
AT
Austria
Prior art keywords
diagnostic system
cytomegalovirus
viral antigen
detecting cytomegalovirus
monoclonal receptor
Prior art date
Application number
AT85902741T
Other languages
English (en)
Inventor
Michael B A Oldstone
George Rice
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/607,387 external-priority patent/US4818678A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE71141T1 publication Critical patent/ATE71141T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Apparatus For Making Beverages (AREA)
  • Control Of Combustion (AREA)
  • Examining Or Testing Airtightness (AREA)
  • Emergency Alarm Devices (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT85902741T 1984-05-04 1985-05-03 Diagnosesystem zum nachweis von cytomegalovirus. ATE71141T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/607,387 US4818678A (en) 1984-05-04 1984-05-04 Diagnostic system for the detection of cytomegalovirus
US06/726,454 US4783399A (en) 1984-05-04 1985-04-29 Diagnostic system for the detection of cytomegalovirus
PCT/US1985/000795 WO1985005123A1 (en) 1984-05-04 1985-05-03 Diagnostic system for the detection of cytomegalovirus
EP85902741A EP0179152B1 (de) 1984-05-04 1985-05-03 Diagnosesystem zum nachweis von cytomegalovirus

Publications (1)

Publication Number Publication Date
ATE71141T1 true ATE71141T1 (de) 1992-01-15

Family

ID=27085503

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85902741T ATE71141T1 (de) 1984-05-04 1985-05-03 Diagnosesystem zum nachweis von cytomegalovirus.

Country Status (13)

Country Link
US (1) US4783399A (de)
EP (1) EP0179152B1 (de)
JP (1) JPH0646196B2 (de)
AT (1) ATE71141T1 (de)
AU (1) AU596073B2 (de)
CA (1) CA1339515C (de)
DE (1) DE3585075D1 (de)
DK (1) DK173584B1 (de)
IE (1) IE58445B1 (de)
IL (1) IL75094A (de)
NZ (1) NZ211989A (de)
PH (1) PH23125A (de)
WO (1) WO1985005123A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
US4908305A (en) * 1987-06-14 1990-03-13 The University Of Maryland Competitive elisa for determination of neutralizing IBDV antibody
JP2607712B2 (ja) 1988-01-29 1997-05-07 カイロン コーポレイション 組換えｃｍｖ中和タンパク
US5547834A (en) * 1988-01-29 1996-08-20 Chiron Corporation Recombinant CMV neutralizing proteins
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
WO1991005876A1 (en) * 1989-10-20 1991-05-02 Children's Biomedical Research Institute Human cytomegalovirus-specific monoclonal antibody cocktail
US5750106A (en) * 1993-01-28 1998-05-12 Novartis Ag Human monoclonal antibodies to cytomegalovirus
RU2123188C1 (ru) * 1997-07-08 1998-12-10 Московский областной научно-исследовательский клинический институт Способ прогнозирования развития цитомегаловирусной инфекции у реципиентов почечных аллотрансплантатов
CN1942483B (zh) 2004-04-13 2012-09-26 弗·哈夫曼-拉罗切有限公司 抗p型选凝素抗体
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
US20110212096A1 (en) * 2006-12-01 2011-09-01 Scott Rollins Anti-p-selectin antibodies and methods of their use and identification
SI2662091T1 (sl) 2006-12-01 2019-01-31 Novartis Ag Protitelesa proti P-selektinu in postopki za njihovo uporabo za zdravljenje vnetnih bolezni
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
US8124093B2 (en) 2008-07-16 2012-02-28 Institute For Research In Biomedicine Human cytomegalovirus neutralizing antibodies and use thereof
KR20140019035A (ko) 2008-09-19 2014-02-13 에프. 호프만-라 로슈 아게 신규한 항체 제형
EP3595645A1 (de) 2017-03-15 2020-01-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmazeutische zusammensetzungen zur behandlung von thrombosen bei patienten mit einem myeloproliferativem neoplasma
EP3642631B1 (de) 2017-06-20 2022-03-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur erkennung, ob patienten mit akuter dekompensierter herzinsuffizienz (adhf) einen hyperkoagulierbaren zustand aufweisen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4334016A (en) * 1980-06-19 1982-06-08 The Wistar Institute Of Anatomy And Biology Human osteogenic sarcoma cell line and use thereof for immunofluorescent antibody test
US4444878A (en) * 1981-12-21 1984-04-24 Boston Biomedical Research Institute, Inc. Bispecific antibody determinants
FR2543570B1 (fr) * 1983-03-31 1985-08-09 Pasteur Institut Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains
GB8404368D0 (en) * 1984-02-20 1984-03-28 Cogent Ltd Monoclonal antibodies to human cytomegalovirus

Also Published As

Publication number Publication date
DE3585075D1 (de) 1992-02-13
EP0179152B1 (de) 1992-01-02
DK2486A (da) 1986-01-03
IE851115L (en) 1985-11-04
JPH0646196B2 (ja) 1994-06-15
AU596073B2 (en) 1990-04-26
US4783399A (en) 1988-11-08
NZ211989A (en) 1989-04-26
AU4351985A (en) 1985-11-28
DK173584B1 (da) 2001-04-02
DK2486D0 (da) 1986-01-03
PH23125A (en) 1989-05-05
IE58445B1 (en) 1993-09-22
JPS61502026A (ja) 1986-09-18
IL75094A (en) 1992-01-15
CA1339515C (en) 1997-10-28
EP0179152A1 (de) 1986-04-30
EP0179152A4 (de) 1988-03-07
WO1985005123A1 (en) 1985-11-21

Similar Documents

Publication Publication Date Title
ATE71141T1 (de) Diagnosesystem zum nachweis von cytomegalovirus.
Yelton et al. Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies
Brown et al. Indirect 125I-labeled protein A assay for monoclonal antibodies to cell surface antigens
Douillard et al. Enzyme-linked immunosorbent assay for screening monoclonal antibody production: use of intact cells as antigen
US4656253A (en) Monoclonal antibodies against alveolar surfactant protein
IL86676A0 (en) Cell line and monoclonal antibodies
DK309285D0 (da) Fremgangsmaade til bestemmelse af immunkomplekser i serum
GB8504104D0 (en) Hcmv monoclonal antibodies
KR890701632A (ko) 사람 인터루킨-4에 대한 모노클로날 항체 및 이를 생성하는 하이브리도마
EP0152477A4 (de) Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.
US4513088A (en) Assay for monoclonal antibody against surface Ig of a human B cell tumor
Beyer A ‘dot-immunobinding assay’on nitrocellulose membrane for the determination of the immunoglobulin class of mouse monoclonal antibodies
ES8605904A1 (es) Metodo inmunologico para la deteccion de celulas malignas con actividad metastatica
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
JPS6428560A (en) Immunometric measurement
EP0157197A3 (en) Method for carrying out immunofluorescent assays
KR900006779A (ko) 항원에 대해 특이적인 종류의 항체 측정 방법 및 이 방법을 실행하기 위한 시약
DE3471661D1 (en) Toxins and antibodies of c. difficile
US4610960A (en) Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
EP0174874A3 (de) Hybridzellinie die für Trichomonas vaginalis zytolytische, monoklonale Antikörper produziert
IL97350A0 (en) Hybridomas producing monoclonal antibodies specific for metolachlor,such antibodies and their use in immunoassays for metolachlor
DE69033260D1 (de) Intrazelluläres Antigen in einer Subpopulation von CD8+T-Lymphozyten und ein monoklonaler Antikörper spezifisch dafür
KR927003838A (ko) 항 인체 플라스민-α2-플라스민 억제물질 복합체 항체, 하이브리도마 및 면역학적 측정방법
ATE80740T1 (de) Immunassay-verfahren.
CA2281262A1 (en) Anti-human medullasin monoclonal antibody, process for producing the same and immunoassay using the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time